Posted: May 6th, 2009, 1:08am CEST by addebook
The Discovery, Use and Impact of Platinum Salts as Chemotherapy Agents for Cancer (Wellcome Witnesses to Twentieth Century Medicine Vol 30)
by: D, A Christie, E, M Tansey
The Discovery, Use and Impact of Platinum Salts as Chemotherapy Agents for Cancer (Wellcome Witnesses to Twentieth Century Medicine Vol 30)
Edited by D.A. Christie and E.M. Tansey. Introduction by Matti Aapro
Product Details
* ISBN: 0854841121
* ISBN-13: 9780854841127
* Format: Paperback, 148pp
* Publisher: Wellcome Institute for the History of Medicine
* Pub. Date: October 2007
* Series: Wellcome Witnesses to Twentieth Century Medicine
* Vol: 30
Proposed by Dr Mark Walport (Wellcome Trust) this Seminar examined the discovery, use and impact of platinum salts as chemotherapy agents for cancer. Organized with the assistance of Professor Paul Andrews (St George’s Hospital Medical School) and Dr Tony Woods (Wellcome Trust) and chaired by Professor Sir Kenneth Calman (Durham) the Seminar discussed the serendipitous emergence of platinum salts as widely used anticancer agents from a chance observation in a microbiology laboratory; through their use especially for the treatment of previously untreatable solid tumours such as those of the testes and ovary; and their significance in the development of antiemetic agents for chemotherapy patients. Participants included chemists, oncologists, and academic and industrial pharmacologists who devised, in particular, the 5HT3 receptor antagonists.
Participants included: Professor Kenneth Bagshawe, Dr Penelope Brock, Professor Hilary Calvert, Professor David Grahame-Smith, Professor Richard Gralla, Professor Kenneth Harrap, Dr James Hoeschele, Professor Ian Judson, Mr Wesley Miner, Professor Robert Naylor, Mrs Brenda Reynolds, Dr John Rudd, Dr Gareth Sanger, Dr David Tattersall, Professor Andrew Thomson, Professor Robert Williams and Dr Eve Wiltshaw.
Contents
Cover
Title Page
Copyright Page
Contents
Illustrations And Credits
Abbreviations
Acknowledgements
History Of Twentieth Century Medicine Witness Seminars,
Witness Seminars:
Published Meetings
Introduction
Transcripts
Participants
Appendix 1 In Praise of Methotrexateby Professor Sir Kenneth Calman
Appendix 2 Structures of some 5HT receptor antagonists
Appendix 3 Components of the emetic reflex
References
Biographical Notes
Glossary
Index: Subject
Index Names
Key to cover photographs
Please Login or Register to read the rest of this content.
Random Posts
- Biology of Microorganisms on Grapes, in Must and in Wine (0)
- Postmortem Toxicology of Abused Drugs (0)
- Scientific and Policy Considerations in Developing Smallpox Vaccination Options: A Workshop Report (0)
- Current Topics in Developmental Biology, Volume 75 (Current Topics in Developmental Biology) (0)
- Foundations of Restoration Ecology: The Science and Practice of Ecological Restoration (0)
- Religion, Culture and Mental Health (0)
Clinical Pharmacology in the UK, c.1950-2000: Influences and institutions (Wellcome Witnesses to Twentieth Century Medicine Vol 33)
by: L A Reynolds, E M Tansey (Editors)
Clinical Pharmacology in the UK, c.1950-2000: Influences and institutions (Wellcome Witnesses to Twentieth Century Medicine Vol 33)
Edited by L.A Reynolds and E.M. Tansey. Introduction by Mark Walport.
Product Details
* ISBN: 0854841172
* ISBN-13: 9780854841172
* Format: Paperback, 168pp
* Publisher: WT Centre for the History of Medicine at UCL
* Pub. Date: November 2008
* Series: Wellcome Witnesses to Twentieth Century Medicine
* Vol: 33
The history of clinical pharmacology in the UK over the last half of the twentieth century is largely untold. Many important new drugs were developed and brought to market in the 1950s and 1960s ensuring the need for more systematic knowledge of drug effects in humans and also providing new career opportunities in teaching, research and practice. The 30th anniversary of the British Journal of Clinical Pharmacology in 2004 and the 75th anniversary of the British Pharmacological Society in 2006 had prompted reflections from practicing clinical pharmacologists. It was timely, therefore, to bring together clinical pharmacologists and others who have shaped the discipline, to promote historical analysis and debate. Chaired by Professor Rod Flower, the meeting considered such questions as: What was/is clinical pharmacology? Which were the main centres of influence? Who and what were the main drivers? Who became clinical pharmacologists and why? What was the significance of specialized societies, meetings and journals?
Participants: Dr Stuart Anderson, Dr Jeffrey Aronson, Professor David Barnett, Dr Linda Beeley, Professor Sir James Black, Professor Morris Brown, Professor Mark Caulfield, Sir Iain Chalmers, Professor Donald Davies, Professor Robin Ferner, Dr Arthur Fowle, Professor Sir Charles George, Professor David Gordon, Professor David Grahame-Smith, Dr Andrew Herxheimer, Dr Kenneth Hunter, Professor Trevor Jones, Professor Desmond Laurence, Professor Denis McDevitt, Professor Walter Nimmo, Professor Michael Orme, Dr Anthony Peck, Professor Laurie Prescott, Professor Brian Prichard, Professor John Reid, Professor James Ritter, Professor Philip Routledge, Professor TilliTansey, Professor Geoffrey Tucker, Professor Patrick Vallance, Professor Duncan Vere, Professor Owen Wade, Professor David Webb and Professor Frank Woods.
Contents
Cover
Clinical Pharmacology in the UK, c.1950-2000: Influences and institutions
Title Page
Copyright Page
Contents
Illustrations And Credits
Witness Seminars:
Acknowledgements
History Of Twentieth Century Medicine Witness Seminars,
Published Meetings
Introduction
Clinical Pharmacology in the UK, c.1950-2000: Influences and institutions Transcripts
Participants
Appendix 1
References
Biographical Notes
Glossary
Index Subject
Index: Names
Key To Cover Photographs
Please Login or Register to read the rest of this content.
Random Posts
- Industrialization of Drug Discovery: From Target Selection Through Lead Optimization (Drug Discovery) (0)
- Cardiac Surgery in the Adult, 3rd edition (0)
- Getting Started in Clinical Radiology: From Image to Diagnosis (0)
- A Look Back at the U.S. Department of Energy’s Aquatic Species Program:Biodiesel from Algae (0)
- Multitrophic Level Interactions (0)
- Computational Biology and Genome Informatics (0)
